Content about New Jersey

December 1, 2011

Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

PITTSBURGH — Generic drug maker Mylan and a partnering company are challenging the patent on a contraceptive drug.

Mylan said Thursday that it and Famy Care had been sued by Warner Chilcott in the U.S. District Court for the District of New Jersey following their filing of a regulatory approval application with the Food and Drug Administration for norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets, a generic version of Warner Chilcott's Generess Fe.

November 30, 2011

National Bio+Green Sciences has created HandSan, which is positioned as the first-ever alcohol-free, organic hand cleanser made solely from purified water and vitamins with no artificial preservatives.

BRANCHBURG, N.J. — National Bio+Green Sciences has created HandSan, which is positioned as the first-ever alcohol-free, organic hand cleanser made solely from purified water and vitamins with no artificial preservatives.

“Like all Bio+Green Crystals products, our HandSan is an eco-friendly product created in America using local components whenever possible, supporting regional and national businesses, and creating quality manufacturing-based jobs,” stated Nik Renieris, founder and CEO of National Bio+Green Sciences.

November 30, 2011

Despite the Centers for Disease Control and Prevention recommending that most people get flu shots, many members of the public remain skeptical, according to a new survey by Vitals.com.

LYNDHURST, N.J. — Despite the Centers for Disease Control and Prevention recommending that most people get flu shots, many members of the public remain skeptical, according to a new survey by Vitals.com.

November 28, 2011

Bayer Healthcare on Monday announced its "Countdown to Holiday Cheer" sweepstakes in support of its Aleve brand.

MORRISTOWN, N.J. — Bayer Healthcare on Monday announced its "Countdown to Holiday Cheer" sweepstakes in support of its Aleve brand. Contestants can enter for a chance to win one of 60 $250 Visa gift cards through Dec. 24 at Aleve.com/holiday. Winners will be announced by Feb. 12.

November 23, 2011

Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

NEW YORK — Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

November 22, 2011

Generic drug maker Par Pharmaceutical has promoted Thomas Haughey to president and Paul Campanelli to COO, the company said. The promotions take effect immediately.

WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical has promoted Thomas Haughey to president and Paul Campanelli to COO, the company said. The promotions take effect immediately.

"With the acquisition of Anchen and the pending acquisition of Edict, Par is becoming a larger and more complex organization with three diverse locations and more than 300 additional employees," Par chairman and CEO Patrick LePore said. "These new challenges and opportunities require a president and COO to effectively manage the company and its subsidiaries."

November 21, 2011

Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

FOSTER CITY, Calif. — Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

Pharmasset, based in Princeton, N.J., is a drug maker that currently has three treatments for hepatitis C undergoing clinical trials, including PSI-7977, which is in late-stage development.

November 18, 2011

Par Pharmaceutical has completed its acquisition of Anchen Pharmaceuticals, the generic drug maker said.

WOODCLIFF LAKE, N.J. — Par Pharmaceutical has completed its acquisition of Anchen Pharmaceuticals, the generic drug maker said.

Par announced plans in August to acquire Irvine, Calif.-based Anchen for $410 million, consisting of a loan and cash it already had.

A privately owned company, Anchen has about 200 employees and more than 72,000 sq. ft. of manufacturing and warehouse space, Par said.

November 17, 2011

Bristol-Myers Squibb and AstraZeneca presented an analysis Wednesday of 14 clinical trials at the American Heart Association's Scientific Sessions in Orlando, Fla., the companies said.

PRINCETON, N.J. — Bristol-Myers Squibb and AstraZeneca presented an analysis Wednesday of 14 clinical trials at the American Heart Association's Scientific Sessions in Orlando, Fla., the companies said.

The phase-2b and phase-3 trials all involved the investigational Type 2 diabetes drug dapagliflozin and, the companies said, showed that use of the drug did not lead to an unacceptable risk to adult patients' cardiovascular health compared with other treatments.

November 17, 2011

Consumers are gravitating toward "natural" over-the-counter remedies, according to a new Kline report, "Natural OTCs 2011: Impact of Non-Drug Products on the U.S. OTC Market," released Wednesday.

PARSIPPANY, N.J. — Consumers are gravitating toward "natural" over-the-counter remedies, according to a new Kline report, "Natural OTCs 2011: Impact of Non-Drug Products on the U.S. OTC Market," released Wednesday.

While the U.S. traditional nonprescription drugs industry registered an average compound annual growth rate of 2.5% between 2005 and 2010, the market for natural OTC remedies has grown at a CAGR of 5.9% per year from 2009 to 2011, according to the research study.

November 17, 2011

Pfizer Consumer Healthcare on Tuesday unveiled a new library at P.S. 130 in the Bronx as part of its Advil Congestion Relief Project.

MADISON, N.J. — Pfizer Consumer Healthcare on Tuesday unveiled a new library at P.S. 130 in the Bronx as part of its Advil Congestion Relief Project. New York Yankee fan favorite Brett Gardner helped unveil a newly decongested library with improved access to computers and books.

November 16, 2011

Unigene Labs, a developer of peptide-based therapeutics, on Wednesday appointed Walgreens' Thomas Sabatino Jr. to its board of directors.

BOONTON, N.J. — Unigene Labs, a developer of peptide-based therapeutics, on Wednesday appointed Walgreens' Thomas Sabatino Jr. to its board of directors.

"[Sabatino's] extensive industry experience and impressive track record — specifically, his knowledge of the legal and regulatory landscape for pharmaceutical companies — will be invaluable as Unigene continues to execute against its business transformation," Unigene chairman Richard Levy said.

November 15, 2011

Actavis has launched an authorized generic drug for treating pain, the company said.

MORRISTOWN, N.J. — Actavis has launched an authorized generic drug for treating pain, the company said.

The drug maker announced Friday that it had started shipping morphine sulfate extended-release capsules, an authorized generic version of Kadian, which it also manufactures. The authorized generic product was launched on the same day as Watson Pharmaceuticals' generic version.

November 15, 2011

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

WASHINGTON — The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

November 15, 2011

Beauty company CCA Industries has appointed Michael Piff as EVP sales.

EAST RUTHERFORD, N.J. — Beauty company CCA Industries has appointed Michael Piff as EVP sales.

Piff joins CCA with extensive industry experience at such companies as DowBrands, Minnetonka Brands and Cosrich/Health Science Labs, and will be based at company headquarters in East Rutherford.

“I look forward to working with Michael as we build CCA’s business and enhance our relationships with the retail trade,” CCA president and CEO Dunnan Edell said.

November 15, 2011

Church and Dwight, the maker of Nair hair removal products, has concluded the second annual "Step Out Challenge" and named a grand-prize winner.

PRINCETON, N.J. — Church and Dwight, the maker of Nair hair removal products, has concluded the second annual "Step Out Challenge" and named a grand-prize winner.

More than 1,400 people who tried Nair shared their smooth skin experiences through written and video testimonials and received free music from Grooveshark, a music-streaming website. The grand-prize winner, Kelly Wilkie from New York, received a weekend experience, including VIP tickets to one of this year's most sought-after concerts.

November 15, 2011

FaVe Juice has launched a line of beverages that provides three servings of vegetables in each 8-oz. glass.

MIDDLETOWN, N.J. — FaVe Juice has launched a line of beverages that provides three servings of vegetables in each 8-oz. glass.

The company said its FaVe 60-calorie, 100% juice blends will be available in strawberry banana kiwi, blueberry pomegranate goji, and orange tangerine pineapple flavors.

FaVe's new line will hit store shelves in early 2012.

November 11, 2011

An appeals court has thrown out an attempt by Teva Pharmaceutical Industries to stop Watson Pharmaceuticals from selling a generic contraceptive, Watson said.

PARSIPPANY, N.J. — An appeals court has thrown out an attempt by Teva Pharmaceutical Industries to stop Watson Pharmaceuticals from selling a generic contraceptive, Watson said.

The U.S. Court of Appeals for the Federal Circuit affirmed a lower court's June 16 decision to deny Duramed Pharmaceuticals' request for an injunction that would stop Watson from selling a generic version of Seasonique (levonorgestrel and ethinyl estradiol [0.15 mg/0.03 mg] and ethinyl estradiol [0.01 mg]). Duramed originally was a subsidiary of Barr Pharmaceuticals, which Teva acquired in 2008.

November 11, 2011

Watson Pharmaceuticals is challenging Swiss drug maker Novartis' patent on a drug used to treat dementia, Watson said.

PARSIPPANY, N.J. — Watson Pharmaceuticals is challenging three of Swiss drug maker Novartis' patents on a drug used to treat dementia, Watson said.

The company said subsidiary Watson Labs had filed for approval generic rivastigmine transdermal system patches in the 4.6-mg and 9.5-mg strengths, both designed to last for 24 hours, with the Food and Drug Administration. The patches are used to treat mild to moderate dementia associated with Alzheimer's or Parkinson's disease.

November 11, 2011

Watson Pharmaceuticals has launched its generic version of an opioid drug for treating pain, the company said Thursday.

PARSIPPANY, N.J. — Watson Pharmaceuticals has launched its generic version of an opioid drug for treating pain, the company said Thursday.

Watson announced the Food and Drug Administration approval and launch of morphine sulfate extended-release capsules.

The drug is a generic version of Actavis' Kadian, which had sales of about $275 million during the 12-month period ended in September, according to IMS Health.

November 10, 2011

Lipton has kicked off an initiative that underscores the brand's efforts to source all of its tea from sustainably managed farms, with the goal of having all of its tea come from Rainforest Alliance Certified farms by 2015.

ENGLEWOOD CLIFFS, N.J. — Lipton has kicked off an initiative that underscores the brand's efforts to source all of its tea from sustainably managed farms, with the goal of having all of its tea come from Rainforest Alliance Certified farms by 2015.

November 8, 2011

Nestlé Healthcare Nutrition on Tuesday launched an enhanced bottle design across its Boost Complete Nutritional Drink line that's grip-friendly, lightweight and that features a no-foil, easy-to-open top.

FLORHAM PARK, N.J. — Nestlé Healthcare Nutrition on Tuesday launched an enhanced bottle design across its Boost Complete Nutritional Drink line that's grip-friendly, lightweight and that features a no-foil, easy-to-open top.

November 4, 2011

Bankrupt grocer A&P has entered into an agreement to receive $490 million of debt and equity financing from investors that will enable it to complete the restructuring of its balance sheet and emerge from Chapter 11 as a private entity in early 2012.

MONTVALE, N.J. — Bankrupt grocer A&P has entered into an agreement to receive $490 million of debt and equity financing from investors that will enable it to complete the restructuring of its balance sheet and emerge from Chapter 11 as a private entity in early 2012.

November 4, 2011

The personal massager category still is small at only $3.2 million for the 12 weeks ended Sept. 4, according to SymphonyIRI Group data across food, drug and mass (excluding Walmart), but the growth rate is trending at a 20.6% clip.


The personal massager category still is small at only $3.2 million for the 12 weeks ended Sept. 4, according to SymphonyIRI Group data across food, drug and mass (excluding Walmart), but the growth rate is trending at a 20.6% clip.


November 4, 2011

The Food and Drug Administration has cleared the way for the return to market of a drug for treating immunodeficiency diseases following its recall by the manufacturer in response to patients developing internal blood clots.

HOBOKEN, N.J. — The Food and Drug Administration has cleared the way for the return to market of a drug for treating immunodeficiency diseases following its recall by the manufacturer in response to patients developing internal blood clots.